Merlin Aspiration System— 510(k) K213771

Name: FDA 510(k) clearance K213771
Creator: U.S. Food and Drug Administration
Published: 2022-01-27

Substantially Equivalent

Mivi Neurovascular, Inc.

FDA 510(k) clearance K213771 for Merlin Aspiration System, Substantially Equivalent on 2022-01-27. Applicant: Mivi Neurovascular, Inc.. Device class: 2.

Clearance details

Applicant: Mivi Neurovascular, Inc.
Product code: Code DXE
Device class: Class 2
Regulation: 21 CFR 870.5150
Advisory panel: Cardiovascular
Date received: 2021-12-02
Decision date: 2022-01-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Eden Prairie, MN, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DXE

view all

K240078 — Fogarty Thru-Lumen Embolectomy Catheter2024-08-28
K241330 — Fogarty Fortis Arterial Embolectomy Catheter2024-07-02
K233819 — Fogarty Venous Thrombectomy Catheters2024-05-22
K233820 — Fogarty Arterial Embolectomy Catheter with Gate Valve2024-05-22
K233619 — Fogarty Corkscrew Catheters; Fogarty Graft Thrombectomy Catheters2024-05-20

Adverse events under product code DXE

product code DXE

Death: 27
Injury: 258
Malfunction: 2,266
Total: 2,551

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.